AI MARKET SCANNING

Prelude Therapeutics Inc

📅 Next Catalyst: Nov 11, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -0.38%
MAX GAP RECORD -5.82%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $PRLD
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 11, 2026 Earnings Release 2026-11-11 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 11, 2026 Earnings Release 2026-08-11 (BEFORE OPEN)
+2.48%
May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN)
+0.00%
Mar 10, 2026 Earnings Release 2026-03-10 (BEFORE OPEN)
-3.24%
Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN)
+2.22%
Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN)
+0.00%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+0.38%
Mar 10, 2025 Earnings Release 2025-03-10 (BEFORE OPEN)
-2.17%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.2%
Bullish Gaps (3)
Bearish Gaps (5)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $PRLD

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-28 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 49m +20.93%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗